Amneal Pharmaceuticals, Inc. (AMRX)
11.92
-0.01
(-0.08%)
USD |
NASDAQ |
May 18, 16:00
11.92
0.00 (0.00%)
After-Hours: 16:51
Amneal Pharmaceuticals Research and Development Expense (Quarterly) : 38.38M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Viatris, Inc. | 245.20M |
| Pfizer Inc. | 2.452B |
| Crinetics Pharmaceuticals, Inc. | 98.92M |
| Prestige Consumer Healthcare, Inc. | -- |
| Amphastar Pharmaceuticals, Inc. | 22.90M |